Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ironwood Pharmaceuticals - 14 Year Stock Price History | IRWD

Historical daily share price chart and data for Ironwood Pharmaceuticals since 2010 adjusted for splits and dividends. The latest closing stock price for Ironwood Pharmaceuticals as of April 24, 2024 is 8.10.
  • The all-time high Ironwood Pharmaceuticals stock closing price was 21.07 on July 17, 2018.
  • The Ironwood Pharmaceuticals 52-week high stock price is 15.70, which is 93.8% above the current share price.
  • The Ironwood Pharmaceuticals 52-week low stock price is 7.53, which is 7% below the current share price.
  • The average Ironwood Pharmaceuticals stock price for the last 52 weeks is 10.43.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ironwood Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 11.1979 12.4100 15.4500 7.6000 8.1000 -29.20%
2023 10.4060 12.2700 12.5600 8.2500 11.4400 -7.67%
2022 11.4795 11.9500 12.8800 9.9000 12.3900 6.26%
2021 11.8168 11.1800 13.9500 9.0400 11.6600 2.37%
2020 10.7107 13.2600 14.0100 8.5800 11.3900 -14.43%
2019 11.3057 10.3800 15.2000 8.2200 13.3100 28.47%
2018 16.2984 15.2700 21.0700 9.3100 10.3600 -30.89%
2017 16.4255 14.8700 19.6100 13.9500 14.9900 -1.96%
2016 12.6613 11.0700 16.7600 7.8000 15.2900 31.92%
2015 13.0219 15.4800 16.6700 9.8300 11.5900 -24.35%
2014 13.4375 12.1500 15.6900 9.7100 15.3200 31.96%
2013 12.9259 11.5400 18.8500 9.2300 11.6100 4.78%
2012 12.7318 11.6000 15.5600 10.4400 11.0800 -7.44%
2011 13.1432 10.4200 16.4000 10.0900 11.9700 15.65%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.268B $0.443B
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic constipation. Ironwood and AbbVie co-develop & co-commercialize Linzess in all other territories world wide. Linzess is marketed by Allergan for IBS-C in Europe and Canada under the brand name Constella. The company receives royalties on sales of Constella in Europe and Canada from AbbVie. In Japan, it has partnered with Astellas Pharma for the development and commercialization of Linzess and with AstraZeneca in China, Hong Kong & Macau. Linzess received approval for IBS-C indication in Japan for chronic constipation and in China for IBS-C. The company completed the spin-off of its soluble guanylate cyclase segment into a separate, publicly traded company, Cyclerion Therapeutics.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.006B 28.36
Chugai Pharmaceutical (CHGCY) Japan $52.738B 22.90
Takeda Pharmaceutical (TAK) Japan $41.871B 6.78
Merck (MKGAF) Germany $20.467B 19.31
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Sandoz Group AG (SDZNY) Switzerland $14.417B 0.00
Shionogi (SGIOY) Japan $14.386B 12.45
Neurocrine Biosciences (NBIX) United States $13.828B 57.43
United Therapeutics (UTHR) United States $11.153B 11.95
Catalent (CTLT) United States $10.126B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.608B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.824B 6.92
Ionis Pharmaceuticals (IONS) United States $6.187B 0.00
Revolution Medicines (RVMD) United States $5.861B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.072B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.015B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.886B 0.00
Indivior (INDV) United States $2.594B 12.06
Summit Therapeutics (SMMT) United States $2.519B 0.00
Corcept Therapeutics (CORT) United States $2.340B 23.66
Dyne Therapeutics (DYN) United States $2.153B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.946B 0.00
PTC Therapeutics (PTCT) United States $1.931B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.863B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.857B 11.00
Evotec AG (EVO) Germany $1.853B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.784B 18.44
Avadel Pharmaceuticals (AVDL) Ireland $1.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Ardelyx (ARDX) United States $1.496B 0.00
Soleno Therapeutics (SLNO) United States $1.314B 0.00
4D Molecular Therapeutics (FDMT) United States $1.241B 0.00
Pacira BioSciences (PCRX) United States $1.205B 11.99
Xencor (XNCR) United States $1.163B 0.00
Collegium Pharmaceutical (COLL) United States $1.160B 7.14
Centessa Pharmaceuticals (CNTA) United Kingdom $0.949B 0.00
Cronos Group (CRON) Canada $0.947B 0.00
Cassava Sciences (SAVA) United States $0.897B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.868B 0.00
Sage Therapeutics (SAGE) United States $0.841B 0.00
USANA Health Sciences (USNA) United States $0.841B 13.24
Relay Therapeutics (RLAY) United States $0.840B 0.00
Enliven Therapeutics (ELVN) United States $0.819B 0.00
ARS Pharmaceuticals (SPRY) United States $0.797B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.727B 0.00
Ocular Therapeutix (OCUL) United States $0.719B 0.00
Silence Therapeutics (SLN) United Kingdom $0.667B 0.00
ProKidney (PROK) United States $0.622B 0.00
Siga Technologies (SIGA) United States $0.616B 9.12
Lyell Immunopharma (LYEL) United States $0.586B 0.00
Savara (SVRA) United States $0.586B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.551B 0.00
Verve Therapeutics (VERV) United States $0.550B 0.00
OmniAb (OABI) United States $0.534B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Altimmune (ALT) United States $0.502B 0.00
Exscientia (EXAI) United Kingdom $0.499B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.445B 0.00
KalVista Pharmaceuticals (KALV) United States $0.437B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Esperion Therapeutics (ESPR) United States $0.403B 0.00
Heron Therapeutics (HRTX) United States $0.398B 0.00
Tourmaline Bio (TRML) United States $0.395B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.55
Harrow (HROW) United States $0.363B 0.00
Bioventus (BVS) United States $0.329B 0.00
Lyra Therapeutics (LYRA) United States $0.312B 0.00
Fractyl Health (GUTS) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
Aquestive Therapeutics (AQST) United States $0.286B 0.00
Nanobiotix S.A (NBTX) France $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.273B 0.00
Black Diamond Therapeutics (BDTX) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.261B 0.00
Pyxis Oncology (PYXS) United States $0.259B 0.00
Nektar Therapeutics (NKTR) United States $0.253B 0.00
Metagenomi (MGX) United States $0.253B 0.00
Adherex Technologies (FENC) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.232B 0.00
Foghorn Therapeutics (FHTX) United States $0.222B 0.00
Avita Medical (RCEL) United States $0.221B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.197B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Century Therapeutics (IPSC) United States $0.192B 0.00
MediWound (MDWD) Israel $0.167B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Incannex Healthcare (IXHL) Australia $0.143B 0.00
Elite Pharmaceuticals (ELTP) United States $0.135B 12.63
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.69
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Inotiv (NOTV) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
GlycoMimetics (GLYC) United States $0.120B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.114B 0.00
OptiNose (OPTN) United States $0.104B 0.00
Eliem Therapeutics (ELYM) United States $0.101B 0.00
FibroGen (FGEN) United States $0.097B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
ProPhase Labs (PRPH) United States $0.091B 0.00
AlloVir (ALVR) United States $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.84
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
JanOne (JAN) United States $0.041B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
Protara Therapeutics (TARA) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
Nutriband (NTRB) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.73
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.10
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.05